Gene Therapy

# Status Description
1994057272 Expired Peripheralization of hematopoietic stem cells
1994057349 Expired Gene therapy for cystic fibrosis
1994067247 Ceased GRB3-3 gene, its variants and their uses
1989037788 Ceased Gene therapy using gene fusions for genetic or acquired disorders
1995028533 Ceased Recombinant vectors derived from adenovirus for use in gene therapy
2014255655 Filed Gene-therapy vectors for treating cardiomyopathy
1995032428 Expired 17q-linked breast and ovarian cancer susceptibility gene
1995033212 Expired In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene
1995033216 Expired Method for diagnosing a predisposition for breast and ovarian cancer
1995026160 Ceased Method for introducing foreign matter into higher eukaryotic cells
1995021863 Expired MTS gene, mutations therein, and methods for diagnosing cancer using MTS gene sequence
1995023789 Expired Germline mutations in the MTS gene and method for detecting predisposition to cancer at the MTS gene
2017200307 Accepted Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination
1999018500 Lapsed Somatic gene therapy to cells associated with fluid spaces
2013207785 Filed Cancer-specific suicide gene for cell-based and gene therapy
2003242459 Granted Primary cultured adipocytes for gene therapy
2000014679 Lapsed Chromosome 17p-linked prostate cancer susceptibility gene
1994071377 Expired Immunologic enhancement with intermittent interleukin-2 therapy
1999021179 Withdrawn Gene therapy using polynucleotide complexes
2011377617 Filed Improved gene therapy methods